Stanley Iyadurai
Chief Tech/Sci/R&D Officer chez CATALYST PHARMACEUTICALS, INC.
Profil
Stanley Iyadurai is currently working as the Senior VP-Medical Affairs & Drug Discovery at Catalyst Pharmaceuticals, Inc. He previously worked as the Director-Neuromuscular Genetics Clinic at The Ohio State University and as the Director-Clinical Research & Development at CSL Behring LLC.
Dr. Iyadurai holds a doctorate degree from the University of Minnesota.
Postes actifs de Stanley Iyadurai
| Sociétés | Poste | Début |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 20/08/2018 |
Anciens postes connus de Stanley Iyadurai
| Sociétés | Poste | Fin |
|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/07/2018 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Formation de Stanley Iyadurai
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
